General
Preferred name
Scyllo-inositol
Synonyms
Scyllitol ()
Scyllitol, Cocositol, Quercinitol, AZD 103, scyllo-Cyclohexanehexol ()
scyllo-inositol ()
Quercinitol ()
ELND-005 ()
ELND005 ()
Scyllo-cyclohexanehexol ()
Inositol, scyllo- ()
AZD-103 ()
Cocositol ()
P&D ID
PD007379
CAS
488-59-5
Tags
available
drug candidate
Drug Status
investigational
Max Phase
2.0
Drug indication
Down syndrome
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
PRICE 29
DESCRIPTION PubChem CID 892 shows the non-chiral inositol structure (GtoPdb)
DESCRIPTION Scyllo-Inositol (Scyllitol) is one of the inositol stereoisomers, rare in the nature, and expected as a promising disease-modifying therapeutic agent for Alzheimer's disease. (TargetMol Bioactive Compound Library)
Compound Sets
13
Cayman Chemical Bioactives
ChEMBL Drugs
Concise Guide to Pharmacology 2017/18
Concise Guide to Pharmacology 2019/20
Concise Guide to Pharmacology 2021/22
Concise Guide to Pharmacology 2023/24
Concise Guide to Pharmacology 2025/26
DrugBank
Guide to Pharmacology
MedChem Express Bioactive Compound Library
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
External IDs
42
Properties
(calculated by RDKit )
Molecular Weight
180.06
Hydrogen Bond Acceptors
6
Hydrogen Bond Donors
6
Rotatable Bonds
0
Ring Count
1
Aromatic Ring Count
0
cLogP
-3.83
TPSA
121.38
Fraction CSP3
1.0
Chiral centers
0.0
Largest ring
6.0
QED
0.23
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target
Amyloid-¦Â
Amyloid-β
Endogenous Metabolite
α-synuclein
Pathway
Neuronal Signaling
Metabolism
Neuroscience
Source data